UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 19, 2006
EDWARDS LIFESCIENCES CORPORATION
(Exact name
of registrant as specified in its charter)
|
Delaware |
|
1-15525 |
|
36-4316614 |
|
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
of incorporation) |
|
file number) |
|
Identification No.) |
|
One Edwards Way, Irvine, California |
|
92614 |
|
(Address of principal executive offices) |
|
(Zip Code) |
(949) 250-2500
Registrant’s telephone number, including area code
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-Commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On September 19, 2006, an affiliate of the Company entered into an Eighth Amendment to the Receivables Purchase Agreement (the “Eighth Amendment”) to amend the Receivables Purchase Agreement, dated as of December 21, 2000, by and among Edwards Lifesciences Financing LLC, Edwards Lifesciences LLC, Variable Funding Capital Company LLC (as assignee of Blue Ridge Asset Funding Corporation) and Wachovia Bank, N.A., as amended (the “Receivables Purchase Agreement”). The Eighth Amendment extends the maturity date of the Receivables Purchase Agreement to September 18, 2007. A copy of the Eighth Amendment is attached as Exhibit 10.1.
|
Item 9.01. |
|
Financial Statements and Exhibits. |
||
|
|
|
|
||
|
(d) |
|
Exhibits |
||
|
|
|
|
||
|
|
|
Exhibit |
|
Description |
|
|
|
|
|
|
|
|
|
10.1 |
|
Eighth Amendment to Receivables Purchase Agreement, dated as of September 19, 2006. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: September 20, 2006 |
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
EDWARDS LIFESCIENCES CORPORATION |
||
|
|
|
|
||
|
|
|
|
||
|
|
|
By: |
/s/ Jay P. Wertheim |
|
|
|
|
|
Jay P. Wertheim |
|
|
|
|
|
Vice President, Associate General Counsel |
|
|
|
|
|
and Secretary |
|
3
Exhibit Index
|
Exhibit |
|
Description |
|
|
|
|
|
10.1 |
|
Eighth Amendment to Receivables Purchase Agreement, dated as of September 19, 2006. |
4